| scholarly article | Q13442814 |
| P50 | author | Robert L Findling | Q90314248 |
| Joseph R Calabrese | Q90776679 | ||
| Stephen Ganocy | Q102174326 | ||
| P2093 | author name string | Keming Gao | |
| David E Kemp | |||
| Philip K Chan | |||
| P2860 | cites work | Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication | Q22253024 |
| Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 | ||
| Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine | Q28469327 | ||
| Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine | Q28580023 | ||
| The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 | ||
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial | Q31048788 | ||
| Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"? | Q31138845 | ||
| Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes | Q33264773 | ||
| Medical and substance use comorbidity in bipolar disorder | Q33835811 | ||
| Excess mortality in bipolar and unipolar disorder in Sweden | Q33954560 | ||
| How to measure comorbidity. a critical review of available methods | Q34194168 | ||
| Cumulative illness rating scale | Q34237005 | ||
| Validation of a measure of physical illness burden at autopsy: the Cumulative Illness Rating Scale | Q34730045 | ||
| The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis? | Q35841353 | ||
| Association between obesity and psychiatric disorders in the US adult population | Q35880425 | ||
| Cumulative Illness Rating Scale was a reliable and valid index in a family practice context | Q36119038 | ||
| A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects | Q36193578 | ||
| Can body mass index help predict outcome in patients with bipolar disorder? | Q36532159 | ||
| Systematic review of multifaceted interventions to improve depression care. | Q36750854 | ||
| Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder | Q37031036 | ||
| Depressive symptoms and metabolic syndrome: is inflammation the underlying link? | Q37052593 | ||
| Allostatic load in bipolar disorder: implications for pathophysiology and treatment | Q37058631 | ||
| Replicable differences in preferred circadian phase between bipolar disorder patients and control individuals | Q37367882 | ||
| Premature mortality from general medical illnesses among persons with bipolar disorder: a review | Q37379526 | ||
| Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap | Q37385194 | ||
| Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome | Q37524747 | ||
| The neurobiology of addictive disorders | Q37616113 | ||
| Translating scientific opportunity into public health impact: a strategic plan for research on mental illness | Q40005693 | ||
| A prospective study of the impact of comorbid medical disease on bipolar disorder outcomes | Q40035386 | ||
| The impact of medical comorbidity on acute treatment in major depressive disorder. | Q42614034 | ||
| Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 | ||
| Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 | ||
| Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial | Q44406161 | ||
| Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics | Q44983319 | ||
| Measuring medical burden using CIRS in older veterans enrolled in UPBEAT, a psychogeriatric treatment program: a pilot study | Q45140803 | ||
| Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 | ||
| Clinical features of bipolar disorder with and without comorbid diabetes mellitus | Q47629610 | ||
| Association of psychiatric disorders and sleep apnea in a large cohort | Q47678781 | ||
| Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome | Q47784382 | ||
| Chronotype and body composition in bipolar disorder | Q48400738 | ||
| Integrating medical and psychiatric care in patients with bipolar disorder. | Q51892747 | ||
| Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder. | Q51894426 | ||
| Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. | Q51898608 | ||
| Relation between cigarette smoking and cognitive function in euthymic individuals with bipolar disorder. | Q51947156 | ||
| The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance | Q52112284 | ||
| Correlates of overweight and obesity in 644 patients with bipolar disorder | Q60646356 | ||
| Prevalence of overweight and obesity in bipolar patients | Q73805994 | ||
| Mortality of patients with mood disorders: follow-up over 34-38 years | Q74294155 | ||
| Abbreviated guidelines for scoring the Cumulative Illness Rating Scale (CIRS) in family practice | Q79508599 | ||
| Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization | Q80000044 | ||
| Medical comorbidity in a bipolar outpatient clinical population | Q80985306 | ||
| A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients | Q82041672 | ||
| P433 | issue | 4 | |
| P921 | main subject | comorbidity | Q1414874 |
| bipolar disorder | Q131755 | ||
| P304 | page(s) | 404-413 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome | |
| P478 | volume | 12 |
| Q33835333 | Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care |
| Q38884279 | Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management |
| Q93092572 | Are remitted affective disorders and familial risk of affective disorders associated with metabolic syndrome, inflammation and oxidative stress? - a monozygotic twin study |
| Q35948836 | Association of quetiapine with ischemic brain stem stroke: a case report and discussion |
| Q37244634 | Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia |
| Q38023889 | Beyond the guidelines for bipolar disorder: practical issues in long-term treatment with lithium. |
| Q48343394 | Bipolar II disorder in patients with a current diagnosis of recurrent depression |
| Q48191720 | Bipolar disorder in women |
| Q40921191 | Bipolar patients referred to specialized services of care: Not resistant but impaired by sub-syndromal symptoms. Results from the FACE-BD cohort |
| Q44142664 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. |
| Q33795131 | Cardiometabolic Health in Bipolar Disorder |
| Q38781602 | Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders |
| Q26747785 | Clinical features, comorbidity, and cognitive impairment in elderly bipolar patients |
| Q34589883 | Comorbid medical illness in bipolar disorder |
| Q36753982 | Correlates of treatment response in depressed older adults with bipolar disorder |
| Q35848001 | DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder. |
| Q37514635 | Dosing patterns and medication adherence in bipolar disorder patients treated with lurasidone: a US retrospective claims database analysis |
| Q61807187 | Elevated Familial Cardiovascular Burden Among Adolescents With Familial Bipolar Disorder |
| Q34309209 | Factors affecting hospital stay in psychiatric patients: the role of active comorbidity. |
| Q37661867 | Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance. |
| Q37213547 | General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. |
| Q57077043 | Genetic Overlap Between Depression and Cardiometabolic Disorders |
| Q59128040 | Genetic Risk for Psychiatric Disorders and Telomere Length |
| Q91825128 | Hepatic gene expression explains primary drug toxicity in bipolar disorder |
| Q50571436 | Insulin resistance in bipolar disorder: relevance to routine clinical care. |
| Q36553562 | Lifestyle interventions targeting dietary habits and exercise in bipolar disorder: A systematic review. |
| Q50627364 | Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). |
| Q40294491 | Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression |
| Q37671101 | Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission |
| Q40317424 | Metabolic Syndrome and Bipolar Affective Disorder: A Review of the Literature |
| Q64085328 | Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives |
| Q36225626 | Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder |
| Q37639334 | Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges |
| Q40945173 | No evidence for metabolic syndrome and lipid profile differences in patients suffering from bipolar I disorder with and without suicide attempts |
| Q36751327 | Obesity and the three-year longitudinal course of bipolar disorder |
| Q36834290 | Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder |
| Q33960389 | PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression |
| Q36269305 | Patient perceptions of physical health and bipolar symptoms: The intersection of mental and physical health |
| Q89665746 | Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes |
| Q48128615 | Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial. |
| Q42509069 | Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder |
| Q30993030 | Staging bipolar disorder: what data and what models are needed? |
| Q37863532 | Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda |
| Q36721281 | The Connection between Cardiac and Mental Disorder: Atrial Fibrillation in Patients with Psychiatric Disorder |
| Q90190210 | The Effect of DHA Supplementation on Cognition in Patients with Bipolar Disorder: An Exploratory Randomized Control Trial |
| Q98226384 | The association between leptin and adiponectin, and metabolic syndrome components and serum levels of lipid peroxidation in bipolar disorder patients treated with lithium and valproic acid |
| Q35167517 | The burden of obesity among adults with bipolar disorder in the United States |
| Q37351069 | The effect of bariatric surgery on psychiatric course among patients with bipolar disorder |
| Q39100917 | The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies |
| Q34983689 | The incidence and relative risk of stroke among patients with bipolar disorder: a seven-year follow-up study |
| Q27687805 | The prevalence and burden of bipolar depression |
| Q38012489 | The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders |
| Q35577365 | Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles |
Search more.